Hysteroscopy Devices Market

Hysteroscopy Devices Market by Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of gynecological disorders, increasing awareness and screening programs of women health along with increasing fertility treatments, and increase in product development activities across the globe.

The hysteroscopy devices market was valued at USD 1,944.86 million in 2024, growing at a CAGR of 6.98% during the forecast period from 2025 to 2032, to reach USD 3,317.92 million by 2032. The increasing incidence of gynecological disorders such as abnormal uterine bleeding, fibroids, and polyps is driving a heightened demand for hysteroscopic evaluations and treatments. This trend is further amplified by several factors, including a growing preference among patients for minimally invasive procedures, which are associated with reduced recovery times and lower complication rates. Office-based hysteroscopy, in particular, is favored for its convenience and higher patient satisfaction compared to traditional surgical settings. 

Additionally, enhanced awareness regarding women's health issues has led to more women seeking medical consultations for gynecological concerns, supported by expanding screening programs that encourage early detection and treatment of conditions like fibroids and polyps. 

Innovations in hysteroscopic technology, including improved imaging techniques and the development of miniaturized, flexible hysteroscopes, have made these procedures safer, more effective, and more accessible, facilitating better diagnosis and treatment outcomes for intrauterine pathologies. A wider array of treatment options available for conditions such as abnormal uterine bleeding and fibroids ranging from hormonal therapies to surgical interventions like hysteroscopic myomectomy has also contributed to the increased adoption of hysteroscopy. Together, these elements are expected to significantly boost the global demand for hysteroscopy devices throughout the forecast period from 2025 to 2032, positioning hysteroscopy as a critical component in modern women's healthcare.

Hysteroscopy Devices Market Dynamics:

According to the recent data and stats provided by the World Health Organization (2023), endometriosis affected roughly 10% (190 million) of reproductive-aged women and girls globally. Endometriosis, characterized by the abnormal growth of uterine tissue outside the uterus, can cause severe pain, bleeding, and infertility. Hysteroscopy offers a minimally invasive approach to directly visualize the uterine cavity, assess the extent of endometrial implants, and guide treatment options such as tissue removal or biopsy thereby boosting the overall market across the globe. Moreover, according to the recent data and stats provided by the Australian Government, in 2022, the estimated number of new cases of gynecological cancer diagnosed in women was 6,777. Additionally, as per the recent data provided by GLOBOCAN (2024), in 2022, the estimated number of new cases of cervix uteri and corpus uteri cancer was 662,000 and 420,000 respectively and the projection was estimated to increase by 909,000 and 639,000 respectively by 2045.

Furthermore, as per the recent data and stats provided by the World Health Organization (2024),  cervical cancer was the fourth most common cancer in women globally with around 660,000 new cases in 2022. The increasing incidence of cervical cancer significantly boosts the market for hysteroscopy devices due to the role of hysteroscopy in the diagnosis, staging, and management of this malignancy. Hysteroscopy provides a detailed visualization of the cervical canal and uterine cavity, enabling clinicians to detect abnormalities, perform biopsies, and assess the spread of cancerous cells with high accuracy thereby escalating the overall market across the globe.

Furthermore, the significance of key market players involved in strategic product development activities is further boosting the overall market of hysteroscopy devices. For instance, in October 2021, Hologic launched its expanded gynecological surgical offering, Omni suite, in Europe, Africa, and the Middle East (EMEA). The expanded offering included a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal.

Thus, the factors mentioned above are likely to boost the market of hysteroscopy devices during the forecasted period.

However, the risks associated with hysteroscopy such as uterine perforation, bleeding, infection, postoperative discomfort, and an increase in product recalls may hinder the future market of hysteroscopy devices.

Hysteroscopy Devices Market Segment Analysis:

Hysteroscopy Devices Market by Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the hysteroscopy devices market, the hysteroscope is expected to have a revenue share in the year 2024. A hysteroscope is a critical instrument, which provides real-time visualization of the uterine cavity, which is essential for diagnosing and treating various gynecological disorders, such as abnormal uterine bleeding, fibroids, polyps, and intrauterine adhesions. The development of advanced hysteroscopes with enhanced imaging capabilities, such as high-definition (HD) and 3D visualization, has greatly improved the accuracy and effectiveness of both diagnostic and operative hysteroscopy. These technological innovations allow for more precise identification and treatment of uterine abnormalities, thereby increasing the procedure's efficacy and reducing the likelihood of repeat surgeries.

Furthermore, the shift towards minimally invasive surgical techniques has made hysteroscopy a preferred option for both patients and healthcare providers. The hysteroscope's ability to perform diagnostic and therapeutic procedures with minimal discomfort, reduced recovery times, and lower risks of complications has led to its widespread adoption.

Moreover, continuous innovations in hysteroscopes are further propelling the overall market across the globe. For instance, in June 2022, UroViu Corp. launched the new Hystero-V, a single-use hysteroscope compatible with UroViu’s Always Ready endoscopy platform. The 12-Fr, semi-rigid Hystero-V featured a hydrophilic coating that enables gentle insertion and provides superior visualization for highly effective intrauterine examinations. This single-use hysteroscope eliminates the need for reprocessing the equipment, and the ease of use, portability, and time-saving aspects of the Hystero-V resulted in more efficient and comfortable procedures for both doctors and patients.

Thus, owing to the above-mentioned factors the segment is expected to generate considerable revenue thereby pushing the overall growth of the global hysteroscopy devices market during the forecast period.

North America is expected to dominate the overall Hysteroscopy Devices market:

Among all the regions, North America is expected to hold the largest share of the hysteroscopy devices market in 2024. This dominance is driven by the rising cases of gynecological disorders like abnormal uterine bleeding, fibroids, cervical cancer, endometriosis, and polyps, increases in awareness and screening programs, increased healthcare initiatives by government and key market players involved in strategic product development activities are expected to boost the market during the forecast period across the region.

According to recent data and stats provided by John Hopkins (2024), endometriosis affected an estimated 2 to 10 percent of American women between the ages of 25 and 40. Additionally, as per the recent data provided by GLOBOCAN (2024), in 2022, the estimated new cases of cervix uteri and corpus uteri were 15,700 and 74,000 respectively and the projections were estimated to increase by 18,200 and 89,500 respectively by 2045. Furthermore, according to the recent data and stats provided by the American Cancer Society (2021), approximately 66,750 new cases of uterine/endometrial cancer were expected to be diagnosed in the same year in the United States. Thus, these conditions often require detailed internal examination and targeted treatment, both of which hysteroscopy is well-suited to provide. Hysteroscopes, with their ability to offer high-resolution imaging and minimally invasive access to the uterine cavity, are increasingly being adopted as the standard diagnostic and therapeutic tools for these conditions. Additionally, as the awareness and screening programs for gynecological health expand, more women are being diagnosed with these disorders at earlier stages, leading to a higher demand for effective and less invasive treatment options. 

Further, growing product approval activities by key market players for the treatment of gynecological disorders in the United States are expected to drive the market growth of hysteroscopy devices. For instance, in May 2024, Meditrina announced the FDA 510(k) clearance of its Gen 2 bipolar RF hysteroscopy system. 

Thus, all the above-mentioned factors are anticipated to propel the market for hysteroscopy devices in North America during the forecast period from 2025 to 2032.

Hysteroscopy Devices Market Key Players:

Some of the key market players operating in the hysteroscopy devices market include Medtronic PLC, Olympus Corporation, Stryker, Hologic., Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, Organon, and others.

Recent Developmental Activities in the Hysteroscopy Devices Market:

• In September 2025, Womed received FDA PreMarket Approval for Womed Leaf®, the first U.S.-approved device for adult women undergoing hysteroscopic surgery to treat symptomatic moderate to severe intrauterine adhesions (Asherman syndrome).
• In January 2023, Organon announced it had made a strategic investment in Claria Medical, Inc., a privately held company developing an investigational device for use during minimally invasive laparoscopic hysterectomy. The agreement also granted Organon the option to acquire Claria Medical.
• In January 2021, Hologic launched Fluent® Fluid Management System for hysteroscopic procedures in Europe.

Key Takeaways From the Hysteroscopy Devices Market Report Study:

• Market size analysis for current hysteroscopy devices size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the hysteroscopy devices market.
• Various opportunities available for the other competitors in the hysteroscopy devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current hysteroscopy devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for hysteroscopy devices market growth in the coming future?

Target Audience Who Can be Benefited From This Hysteroscopy Devices Market Report Study:

• Hysteroscopy device product providers
• Research organizations and consulting companies 
• Hysteroscopy devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in hysteroscopy devices 
• Various end-users who want to know more about the hysteroscopy devices market and the latest technological developments in the hysteroscopy devices market.  

Frequently Asked Questions for the Hysteroscopy Devices Market:

1. What are hysteroscopy devices?

• Hysteroscopy devices are medical tools used to examine the inside of the uterus. They include a hysteroscope, a thin, lighted tube inserted through the cervix to provide visuals of the uterine cavity, and may also feature devices for performing diagnostic or surgical procedures, such as removing polyps or fibroids.

2. What is the market for hysteroscopy devices?

• The hysteroscopy devices market was valued at USD 1,944.86 million in 2024, growing at a CAGR of 6.98% during the forecast period from 2025 to 2032, to reach USD 3,317.92 million by 2032. 

3. What are the drivers for the hysteroscopy devices market?

• The growing prevalence of gynecological disorders like abnormal uterine bleeding, fibroids, and polyps is increasing the demand for hysteroscopic evaluations and treatments. Additionally, the growing preference for minimally invasive procedures, growing awareness regarding women's health, increasing screening programs, and advancements in hysteroscopic technology such as improved imaging and precise tools are also contributing to the rising adoption of these devices, expanding their use and boosting the market. Together, these factors are expected to increase the demand for hysteroscopy devices across the globe during the forecast period from 2025 to 2032.

4. Who are the key players operating in the hysteroscopy devices market?

• Some of the key market players operating in the hysteroscopy devices market include Medtronic PLC, Olympus Corporation, Stryker, Hologic., Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, Organon, and others.

5. Which region has the highest share in the hysteroscopy devices market?

• Among all the regions, North America is expected to hold the largest share of the hysteroscopy devices market in 2024. This dominance is driven by the rising cases of gynecological disorders like abnormal uterine bleeding, fibroids, cervical cancer, endometriosis, and polyps, increases in awareness and screening programs, increased healthcare initiatives by government and key market players involved in strategic product development activities are expected to boost the market during the forecast period across the region.